Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A report of familial hyperphosphataemia in an Irish family.

× No keyword cloud information.

10 in total

Review 1. Sodium-dependent phosphate co-transporters.

Authors: E Takeda; Y Taketani; K Morita; K Miyamoto
Journal: Int J Biochem Cell Biol Date: 1999 Mar-Apr Impact factor: 5.085

2. The excretion of acid in renal disease.

Authors: O WRONG; H E DAVIES
Journal: Q J Med Date: 1959-04

3. Tumoral calcinosis.

Authors: D Berg
Journal: Br J Surg Date: 1972-07 Impact factor: 6.939

4. Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect.

Authors: T Nesbitt; T M Coffman; R Griffiths; M K Drezner
Journal: J Clin Invest Date: 1992-05 Impact factor: 14.808

5. Imaging of tumoral calcinosis: new observations.

Authors: S Martinez; J B Vogler; J M Harrelson; K W Lyles
Journal: Radiology Date: 1990-01 Impact factor: 11.105

6. Hyperphosphataemic tumoral calcinosis in Bedouin Arabs--clinical and radiological features.

Authors: F E McGuinness
Journal: Clin Radiol Date: 1995-04 Impact factor: 2.350

7. Genetic transmission of tumoral calcinosis: autosomal dominant with variable clinical expressivity.

Authors: K W Lyles; E J Burkes; G J Ellis; K J Lucas; E A Dolan; M K Drezner
Journal: J Clin Endocrinol Metab Date: 1985-06 Impact factor: 5.958

8. A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets.

Authors: M J Econs; N E Friedman; P S Rowe; M C Speer; F Francis; T M Strom; C Oudet; J A Smith; J T Ninomiya; B E Lee; H Bergen
Journal: J Clin Endocrinol Metab Date: 1998-10 Impact factor: 5.958

9. Tumoral calcinosis in England.

Authors: G Slavin; L Klenerman; A Darby; S Bansal
Journal: Br Med J Date: 1973-01-20

10. Hyperphosphatemic tumoral calcinosis: association with elevation of serum 1,25-dihydroxycholecalciferol concentrations.

Authors: M J Prince; P C Schaeffer; R S Goldsmith; A B Chausmer
Journal: Ann Intern Med Date: 1982-05 Impact factor: 25.391

10 in total

3 in total

1. An ocular presentation of familial tumoral calcinosis.

Authors: Emer McGrath; Fiona Harney; Frank Kinsella
Journal: BMJ Case Rep Date: 2010-09-20

Review 2. Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management.

Authors: Alison M Boyce; Alisa E Lee; Kelly L Roszko; Rachel I Gafni
Journal: Front Endocrinol (Lausanne) Date: 2020-05-08 Impact factor: 5.555

Review 3. Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature.

Authors: Silje Rafaelsen; Stefan Johansson; Helge Ræder; Robert Bjerknes
Journal: BMC Genet Date: 2014-09-24 Impact factor: 2.797

3 in total